Disclosures for "exPDite-2: A Phase Three, Randomized, Sham-controlled, Double-blind Trial to Evaluate Bemdaneprocel, a Midbrain Dopaminergic Neuron Progenitor Cell Therapy for Parkinson’s Disease"
-
Dr. Abid has received personal compensation for serving as an employee of BlueRock Therapeutics.
-
Dr. Adera has received personal compensation for serving as an employee of Ovid Therapeutics. Dr. Adera has received stock or an ownership interest from Ovid Therapeutics.
-
Dr. Louie-Gao has received personal compensation for serving as an employee of Bluerock Therapeutics. Dr. Louie-Gao has received personal compensation for serving as an employee of Wave Life Science.
-
Dr. Belfort has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Belfort has received stock or an ownership interest from Praxis Precision Medicines. Dr. Belfort has received intellectual property interests from a discovery or technology relating to health care.